Expression of HCV structural proteins impairs IFN-mediated antiviral response

Virology

Volumn 299, Issue 2, 2002, Pages 164-171

  Keskinen, Päivi ^a   Melén, Krister ^a   Julkunen, Ilkka ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Antiviral response; Hepatitis C; Interferons; Mx protein; Oligoadenylate synthetase; Vesicular stomatis virus

Indexed keywords

ALPHA INTERFERON; CORE PROTEIN; NONSTRUCTURAL PROTEIN 5A; PROTEIN NS3A; PROTEIN NS4A; STRUCTURAL PROTEIN; TETRACYCLINE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANTIVIRAL ACTIVITY; ARTICLE; CELL LINE; CONTROLLED STUDY; GENOTYPE; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; VESICULAR STOMATITIS VIRUS; VIRUS CORE; VIRUS GENOME; VIRUS REPLICATION;

HEPATITIS C VIRUS; VESICULAR STOMATITIS VIRUS;

EID: 0036435567     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2002.1527     Document Type: Article

References (45)

1. Aizaki, H., Saito, S., Ogino, T., Miyajima, N., Harada, T., Matsuura, Y., Miyamura, T., and Kohase, M. (2000). Suppression of interferon-induced antiviral activity in cells expressing hepatitis C virus proteins. J. Interferon Cytokine Res. 20, 1111-1120.
2. Alter, M. (1995). Epidemiology of hepatitis C in the West. Semin. Liver Dis. 15, 5-14.
3. Bartenschlager, R., and Lohmann, V. (2000). Replication of hepatitis C virus. J. Gen. Virol., 81, 1631-1648.
4. Brass, V., Bieck, E., Montserret, R., Wolk, B., Hellings, J. A., Blum, H. E., Penin, F., and Moradpour, D. (2002). An amino-terminal amphipathic alpha-helix mediates membrane association of the hepatitis C virus nonstructural protein 5A. J. Biol. Chem. 277, 8130-8139.
5. Bruno, S., Silini, E., Crosignani, A., Borzio, F., Leandro, G., Bono, F., Asti, M., Rossi, S., Larghi, A., Cerino, A., Podda, M., and Mondelli, M. U. (1997). Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: A prospective study. Hepatology 25, 754-758.
6. Cantell, K., Hirvonen, S., and Kauppinen, H. L. (1986). Production and partial purification of human immune interferon. Methods Enzymol. 119, 54-63.
7. Cantell, K., Hirvonen, S., Kauppinen, H. L., and Kalkkinen, N. (1991). Rapid production of interferon-gamma in uninduced human leukocyte suspensions. J. Interferon Res. 11, 231-236.
8. Cantell, K., Hirvonen, S., Kauppinen, H. L., and Myllyla, G. (1981). Production of interferon in human leukocytes from normal donors with the use of Sendai virus. Methods Enzymol. 78, 29-38.
9. Cerny, A., and Chisari, F. V. (1999). Pathogenesis of chronic hepatitis C: Immunological features of hepatic injury and viral persistence. Hepatology 30, 595-601.
10. Cooper, S., Erickson, A. L., Adams, E. J., Kansopon, J., Weiner, A. J., Chien, D. Y., Houghton, M., Parham, P., and Walker, C. M. (1999). Analysis of a successful immune response against hepatitis C virus. Immunity 10, 439-449.
11. Davis, G. L., Esteban-Mur, R., Rustgi, V., Hoefs, J., Gordon, S. C., Trepo, C., Shiffman, M. L., Zeuzem, S., Craxi, A., Ling, M. H., and Albrecht, J. (1998). Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group. N. Engl. J. Med. 339, 1493-1499.
12. Diepolder, H. M., Zachoval, R., Hoffmann, R. M., Jung, M. C., Gerlach, T., and Pape, G. R. (1996). The role of hepatitis C virus specific CD43 T lymphocytes in acute and chronic hepatitis C. J. Mol. Med. 74, 583-588.
13. Francois, C., Duverlie, G., Rebouillat, D., Khorsi, H., Castelain, S., Blum, H. E., Gatignol, A., Wychowski, C., Moradpour, D., and Meurs, E. F. (2000). Expression of hepatitis C virus proteins interferes with the antiviral action of interferon independently of PKR-mediated control of protein synthesis. J. Virol. 74, 5587-5596.
14. Frese, M., Pietschmann, T., Moradpour, D., Haller, O., and Bartenschlager, R. (2001). Interferon-alpha inhibits hepatitis C virus sub-genomic RNA replication by an MxA-independent pathway. J. Gen. Virol. 82, 723-733.
15. Gale, M., Jr., Blakely, C. M., Kwieciszewski, B., Tan, S. L., Dossett, M., Tang, N. M., Korth, M. J., Polyak, S. J., Gretch, D. R., and Katze, M. G. (1998). Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: Molecular mechanisms of kinase regulation. Mol. Cell. Biol. 18, 5208-5218.
16. Gale, M., Jr., Kwieciszewski, B., Dossett, M., Nakao, H., and Katze, M. G. (1999). Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase. J. Virol. 73, 6506-6516.
17. Heim, M. H., Moradpour, D., and Blum, H. E. (1999). Expression of hepatitis C virus proteins inhibits signal transduction through the Jak-STAT pathway. J. Virol. 73, 8469-8475.
18. Hoofnagle, J. H., and di Bisceglie, A. M. (1997). The treatment of chronic viral hepatitis. N. Engl. J. Med. 336, 347-356.
19. Hugle, T., Fehrmann, F., Bieck, E., Kohara, M., Krausslich, H. G., Rice, C. M., Blum, H. E., and Moradpour, D. (2001). The hepatitis C virus nonstructural protein 4B is an integral endoplasmic reticulum membrane protein. Virology 284, 70-81.
20. Kato, N., Yoshida, H., Kioko Ono-Nita, S., Kato, J., Goto, T., Otsuka, M., Lan, K., Matsushima, K., Shiratori, Y., and Omata, M. (2000). Activation of intracellular signaling by hepatitis B and C viruses, C-viral core is the most potent signal transducer. Hepatology 32, 405-412.
21. Keskinen, P., Nyqvist, M., Sareneva, T., Pirhonen, J., Melén, K., and Julkunen, I. (1999). Impaired antiviral response in human hepatoma cells. Virology 263, 364-375.
22. Keskinen, P., Ronni, T., Matikainen, S., Lehtonen, A., and Julkunen, I. (1997). Regulation of HLA class I and II expression by interferons and influenza A virus in human peripheral blood mononuclear cells. Immunology 91, 421-429.
23. Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
24. Large, M., Kittlesen, D., and Hahn, Y. (1999). Suppression of host immune response by the core protein of hepatitis C virus: Possible implications for hepatitis C virus persistence. J. Immunol. 162, 931-938.
25. Lehtonen, A., Matikainen, S., and Julkunen, I. (1997). Interferons up-regulate STAT1, STAT2, and IRF family transcription factor gene expression in human peripheral blood mononuclear cells and macrophages. J. Immunol. 159, 794-803.
26. McHutchison, J. G., Gordon, S. C., Schiff, E. R., Shiffman, M. L., Lee, W. M., Rustgi, V. K., Goodman, Z. D., Ling, M. H., Cort, S., and Albrecht, J. K. (1998). Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N. Engl. J. Med. 339, 1485-1492.
27. Melén, K., Keskinen, P., Lehtonen, A., and Julkunen, I. (2000). Interferon-induced gene expression and signaling in human hepatoma cell lines. J. Hepatol. 33, 764-772.
28. Melén, K., Keskinen, P., Ronni, T., Sareneva, T., Lounatmaa, K., and Julkunen, I. (1996). Human MxB protein, an interferon-alpha-inducible GTPase, contains a nuclear targeting signal and is localized in the heterochromatin region beneath the nuclear envelope. J. Biol. Chem. 271, 23478-23486.
29. Moradpour, D., Grabscheid, B., Kammer, A. R., Schmidtke, G., Groettrup, M., Blum, H. E., and Cerny, A. (2001). Expression of hepatitis C virus proteins does not interfere with major histocompatibility complex class I processing and presentation in vitro. Hepatology 33, 1282-1287.
30. Moradpour, D., Kary, P., Rice, C. M., and Blum, H. E. (1998). Continuous human cell lines inducibly expressing hepatitis C virus structural and nonstructural proteins. Hepatology 28, 192-201.
31. Park, K. J., Choi, S. H., Lee, S. Y., Hwang, S. B., and Lai, M. M. (2002). Nonstructural 5A protein of hepatitis C virus modulates tumor necrosis factor alpha-stimulated nuclear factor kappa B activation. J. Biol. Chem. 277, 13122-13128.
32. Pirhonen, J., Sareneva, T., Kurimoto, M., Julkunen, I., and Matikainen, S. (1999). Virus infection activates IL-1 beta and IL-18 production in human macrophages by a caspase-1-dependent pathway. J. Immunol. 162, 7322-7329.
33. Podevin, P., Sabile, A., Gajardo, R., Delhem, N., Abadie, A., Lozach, P. Y., Beretta, L., and Brechot, C. (2001). Expression of hepatitis C virus NS5A natural mutants in a hepatocytic cell line inhibits the antiviral effect of interferon in a PKR-independent manner. Hepatology 33, 1503-1511.
34. Polyak, S. J., Paschal, D. M., McArdle, S., Gale, M. J., Jr., Moradpour, D., and Gretch, D. R. (1999). Characterization of the effects of hepatitis C virus nonstructural 5A protein expression in human cell lines and on interferon-sensitive virus replication. Hepatology 29, 1262-1271.
35. Poynard, T., Leroy, V., Cohard, M., Thevenot, T., Mathurin, P., Opolon, P., and Zarski, J. P. (1996). Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: Effects of dose and duration. Hepatology 24, 778-789.
36. Ray, R. B., Meyer, K., Steele, R., Shrivastava, A., Aggarwal, B. B., and Ray, R. (1998). Inhibition of tumor necrosis factor (TNF-alpha)-mediated apoptosis by hepatitis C virus. J. Biol. Chem. 273, 2256-2259.
37. Reed, K. E., and Rice, C. M. (2000). Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties. Curr. Top. Microbiol. Immunol. 242, 55-84.
38. Saito, I., Miyamura, T., Ohbayashi, A., Harada, H., Katayama, T., Kikuchi, S., Watanabe, Y., Koi, S., Onji, M., Ohta, Y., et al. (1990). Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA 87, 6547-6549.
39. Schmidt-Mende, J., Bieck, E., Hugle, T., Penin, F., Rice, C. M., Blum, H. E., and Moradpour D. (2001). Determinants for membrane association of the hepatitis C virus RNA-dependent RNA polymerase. J. Biol. Chem. 276, 44052-44063.
40. Song, J., Fujii, M., Wang, F., Itoh, M., and Hotta, H. (1999). The NS5A protein of hepatitis C virus partially inhibits the antiviral activity of interferon. J. Gen. Virol. 80, 879-886.
41. Stark, G. R., Kerr, I. M., Williams, B. R., Silverman, R. H., and Schreiber, R. D. (1998). How cells respond to interferons. Annu. Rev. Biochem. 67, 227-264.
42. Stutvoet, S. T. D., Bieck, E., Blum, H. E., Heim, M. H., and Moradpour, D. (2002). Expression of Hepatitis C Virus Structural Proteins Inhibits Interferon-3 Induced Signaling through the Jak-STAT Pathway. Submitted for publication.
43. Tan, S. L., and Katze, M. G. (2001). How hepatitis C virus counteracts the interferon response: The jury is still out on NS5A. Virology 284, 1-12.
44. Taylor, D. R., Shi, S. T., Romano, P. R., Barber, G. N., and Lai, M. M. (1999). Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. Science 285, 107-110.
45. Wolk, B., Sansonno, D., Krausslich, H. G., Dammacco, F., Rice, C. M., Blum, H. E., and Moradpour, D. (2000). Subcellular localization, stability, and trans-cleavage competence of the hepatitis C virus NS3-NS4A complex expressed in tetracycline-regulated cell lines. J. Virol. 74, 2293-2304.